Voice your opinion on congressional bill HR2296-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Fair Accountability and Innovative Research Drug Pricing Act of 2019 or the FAIR Drug Pricing Act of 2019

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

HR3-116, HR19-116, HR2087-116, HR2115-116, HR2376-116, HR2452-116, HR3408-116, HR3415-116, S1227-116, S1391-116, S1895-116, S2051-116, HR7898-116,

House floor actions Actions

Calendars
Sep. 24 2019	Placed on the Union Calendar, Calendar No. 170.

Committee
Sep. 24 2019	Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.

IntroReferral
Apr. 12 2019	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

Committee
Sep. 24 2019	Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.

IntroReferral
Apr. 12 2019	Introduced in House Introduced in House

House committee actions Actions

Committee
Jul. 17 2019	Ordered to be Reported (Amended) by Voice Vote. Committee Consideration and Mark-up Session Held.
Jul. 11 2019	Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . Subcommittee Consideration and Mark-up Session Held.
May. 21 2019	Subcommittee Hearings Held.
Apr. 15 2019	Referred to the Subcommittee on Health.

House bill HR2296-116

More Efficient Tools to Realize Information for Consumers Act

House bill HR2296-116

More Efficient Tools to Realize Information for Consumers Act

Promote the cause!

Or use this QR code